Citation: | Tang LJ,Li XM,Zhang XW,et al.Effects of advanced platelet-rich fibrin on deep partial-thickness burn wounds in nude mice[J].Chin J Burns Wounds,2023,39(8):771-778.DOI: 10.3760/cma.j.cn501225-20220804-00334. |
[1] |
HettiaratchyS,DziewulskiP.ABC of burns: pathophysiology and types of burns[J].BMJ,2004,328(7453):1427-1429.DOI: 10.1136/bmj.328.7453.1427.
|
[2] |
PeckMD.Epidemiology of burns throughout the world. Part I: distribution and risk factors[J].Burns,2011,37(7):1087-1100.DOI: 10.1016/j.burns.2011.06.005.
|
[3] |
GragnaniA, TonarelliE, ChomiskiV, et al. Fibroblast growth factor in the treatment of burns: a systematic review[J].Burns,2022,48(1):104-110.DOI: 10.1016/j.burns.2021.04.006.
|
[4] |
ShuWT, WangYN, ZhangX, et al. Functional hydrogel dressings for treatment of burn wounds[J]. Front Bioeng Biotechnol,2021,9:788461.DOI: 10.3389/fbioe.2021.788461.
|
[5] |
HermansMH.Porcine xenografts vs. (cryopreserved) allografts in the management of partial thickness burns: is there a clinical difference?[J].Burns,2014,40(3):408-415.DOI: 10.1016/j.burns.2013.08.020.
|
[6] |
WangY, BeekmanJ, HewJ, et al. Burn injury: challenges and advances in burn wound healing, infection, pain and scarring[J]. Adv Drug Deliv Rev,2018,123:3-17.DOI: 10.1016/j.addr.2017.09.018.
|
[7] |
HexterAT,Sanghani-KeraiA,HeidariN,et al.Mesenchymal stromal cells and platelet-rich plasma promote tendon allograft healing in ovine anterior cruciate ligament reconstruction[J].Knee Surg Sports Traumatol Arthrosc,2021,29(11):3678-3688.DOI: 10.1007/s00167-020-06392-9.
|
[8] |
KarimiK, RockwellH. The benefits of platelet-rich fibrin[J]. Facial Plast Surg Clin North Am,2019,27(3):331-340.DOI: 10.1016/j.fsc.2019.03.005.
|
[9] |
NakanishiY, MatsushitaT, NagaiK, et al. Fibrin clot and leukocyte-rich platelet-rich fibrin show similar release kinetics and amount of growth factors: a pilot study[J]. J Orthop Surg Res,2023,18(1):238.DOI: 10.1186/s13018-023-03709-5.
|
[10] |
WangPH,HuangBS,HorngHC,et al.Wound healing[J].J Chin Med Assoc,2018,81(2):94-101.DOI: 10.1016/j.jcma.2017.11.002.
|
[11] |
KwonSH,BarreraJA,NoishikiC,et al.Current and emerging topical scar mitigation therapies for craniofacial burn wound healing[J].Front Physiol,2020,11:916.DOI: 10.3389/fphys.2020.00916.
|
[12] |
ZubairM, AhmadJ. Role of growth factors and cytokines in diabetic foot ulcer healing: a detailed review[J]. Rev Endocr Metab Disord,2019,20(2):207-217.DOI: 10.1007/s11154-019-09492-1.
|
[13] |
MironRJ,DhamA,DhamU,et al.The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet-rich fibrin (PRF) membranes[J].Clin Oral Investig,2019,23(5):2179-2185.DOI: 10.1007/s00784-018-2673-x.
|
[14] |
BoltonL. Platelet-rich plasma: optimal use in surgical wounds[J]. Wounds,2021,33(8):219-221. DOI: 10.25270/wnds/2021.219221.
|
[15] |
Vidán-EstévezJ, Sánchez-HerráezS, Escalante-BarrigónF, et al. Healing of chronic wounds with platelet-derived growth factors from single donor platelet-rich plasma following one freeze-thaw cycle. A cross-sectional study[J]. J Clin Med,2021,10(24):5762.DOI: 10.3390/jcm10245762.
|
[16] |
OlivaN,AlmquistBD.Spatiotemporal delivery of bioactive molecules for wound healing using stimuli-responsive biomaterials[J].Adv Drug Deliv Rev,2020,161-162:22-41.DOI: 10.1016/j.addr.2020.07.021.
|
[17] |
Castillo-HenríquezL, Castro-AlpízarJ, Lopretti-CorreaM, et al. Exploration of bioengineered scaffolds composed of thermo-responsive polymers for drug delivery in wound healing[J]. Int J Mol Sci,2021,22(3):1408.DOI: 10.3390/ijms22031408.
|
[18] |
LiuMQ, WeiXR, ZhengZJ, et al. Recent advances in nano-drug delivery systems for the treatment of diabetic wound healing[J]. Int J Nanomedicine,2023,18:1537-1560.DOI: 10.2147/IJN.S395438.
|
[19] |
ShahSA, SohailM, KhanS, et al. Biopolymer-based biomaterials for accelerated diabetic wound healing: a critical review[J]. Int J Biol Macromol,2019,139:975-993.DOI: 10.1016/j.ijbiomac.2019.08.007.
|
[20] |
García-SánchezJM, Mirabet LisV, Ruiz-VallsA, et al. Platelet rich plasma and plasma rich in growth factors for split-thickness skin graft donor site treatment in the burn patient setting: a randomized clinical trial[J].Burns,2022,48(7):1662-1670.DOI: 10.1016/j.burns.2021.10.001.
|
[21] |
BernatchezSF, BichelJ. The science of skin: measuring damage and assessing risk[J]. Adv Wound Care (New Rochelle),2023,12(4):187-204.DOI: 10.1089/wound.2022.0021.
|
[22] |
ShenSH,WangFY,FernandezA,et al.Role of platelet-derived growth factor in type Ⅱ diabetes mellitus and its complications[J].Diab Vasc Dis Res,2020,17(7):1479164120942119.DOI: 10.1177/1479164120942119.
|
[23] |
CuiHS, ChoYS, JooSY, et al. Wound healing potential of low temperature plasma in human primary epidermal keratinocytes[J]. Tissue Eng Regen Med,2019,16(6):585-593.DOI: 10.1007/s13770-019-00215-w.
|
[24] |
GaroufaliaZ, PapadopetrakiA, KaratzaE, et al. Insulin-like growth factor-I and wound healing, a potential answer to non-healing wounds: a systematic review of the literature and future perspectives[J]. Biomed Rep,2021,15(2):66.DOI: 10.3892/br.2021.1442.
|
[25] |
FangZ,YangX,WuG,et al.The use of autologous platelet-rich plasma gel increases wound healing and reduces scar development in split-thickness skin graft donor sites[J].J Plast Surg Hand Surg,2019,53(6):356-360.DOI: 10.1080/2000656X.2019.1635489.
|
[26] |
OgaiK,ShibataK,TakahashiN,et al.Amplicon-based skin microbiome profiles collected by tape stripping with different adhesive film dressings: a comparative study[J].BMC Microbiol,2021,21(1):54.DOI: 10.1186/s12866-021-02122-4.
|
[27] |
GuptaA, ChannaveeraC, SethiS, et al. Efficacy of intralesional platelet-rich plasma in diabetic foot ulcer[J]. J Am Podiatr Med Assoc,2021,111(3):Article_7.DOI: 10.7547/19-149.
|
[28] |
洪武,李少峰,林钰梅.富血小板纤维蛋白联合网状中厚皮植皮在手背深度烧伤创面中的应用[J].中国医药科学,2022,12(21):193-196.DOI: 10.3969/j.issn.2095-0616.2022.21.049.
|
[29] |
刘中波,周大鹏,左娜,等.富血小板纤维蛋白联合薄中厚皮片治疗小面积深度皮肤损伤的临床研究[J].中国临床实用医学,2023,14(2):46-49.DOI: 10.3760/cma.j.cn115570-20230107-00011.
|